Startseite Evaluation of creatine kinase level during long-term tocolysis
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Evaluation of creatine kinase level during long-term tocolysis

  • Y. Matsuda , Y. Nagayoshi und N. Kirihara
Veröffentlicht/Copyright: 1. Juni 2005
Journal of Perinatal Medicine
Aus der Zeitschrift Band 30 Heft 6

Abstract

Objective: This study was performed to evaluate serum creatine kinase (CK) levels during tocolytic therapy. Methods: A retrospective study was performed in 27 patients who were treated with intravenous tocolytic agents for more than one week. The first-line tocolytic agent was ritodrine hydrochloride, followed by concomitant magnesium sulfate (MgSO4). The serum CK level was measured on admission and every week thereafter. The patients were divided into the normal CK (group 1) and abnormal CK (> 150 IU/L) (group 2) groups. Results: Seventeen patients received both ritodrine hydrochloride and MgSO4. The CK levels in all patients rose significantly from 58.4 ± 30.8 IU/L on admission 116.0 ± 68.7 IU/L on day 7 (p = 0.002). Abnormal elevation of CK occurred in 7 (25.9%) of the 27 patients. Significant differences were found between groups 1 and 2 in the total doses of ritodrine and MgSO4 (p = 0.046 and 0.0028, respectively). All patients in group 2 received ritodrine in combination with MgSO4 (p = 0.018). Conclusion: When tocolytic therapy continued for more than 1 week, nearly one-fourth of patients showed an increase in CK level above the normal range.

:
Published Online: 2005-06-01
Published in Print: 2002-12-03

Copyright © 2002 by Walter de Gruyter GmbH & Co. KG

Heruntergeladen am 13.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/JPM.2002.074/html
Button zum nach oben scrollen